Antibody Fragment Conjugate Mixture for Targeted Therapy
Blend of antibody fragments and conjugates for precise immune targeting in autoimmune diseases. HTS 3002.14.00.90 for mixed, non-retail immunological products including antibody conjugates per chapter notes.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If put up in measured doses
3002.15 specifically for dosed immunological products.
If for chemical contraceptive immunologicals
Note 6(h) carves out specific hormone-based products to 3006.
If pure diagnostic reagent use
Diagnostic-only excludes from chapter 30 per note 1(i).
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right HTS code — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Include immunogenicity risk assessments in import docs
• Confirm non-measured dose via bulk container specs
• Watch for reclassification if conjugated to diagnostic markers
Related Products under HTS 3002.14.00.90
Mixed Monoclonal Antibody Cocktail for Cancer Immunotherapy
This product is a blend of multiple monoclonal antibodies (e.g., pembrolizumab and nivolumab derivatives) designed for immunotherapy treatment of solid tumors. It falls under HTS 3002.14.00.90 as mixed immunological products not in measured doses or retail packaging, per chapter notes defining immunological products as peptides/proteins regulating immunological processes.
Blended Interferon-Alpha and Interleukin-2 Therapy
A mixed preparation of recombinant interferon-alpha and interleukin-2 for treating viral infections and boosting immune response in immunotherapy. Classified in HTS 3002.14.00.90 as mixed immunological products (interferons and interleukins per chapter notes) not for retail sale.
Cytokine Mixture for Immunomodulation (TNF and Growth Factors)
Bulk mixed solution of tumor necrosis factors (TNF) and growth factors for regulating immune responses in clinical settings. HTS 3002.14.00.90 applies to these mixed immunological products (TNF/GF per notes) not in retail forms.
Hematopoietin and Colony Stimulating Factor Blend
Mixed hematopoietins and colony stimulating factors (CSF) for bone marrow stimulation in chemotherapy patients. Fits HTS 3002.14.00.90 as mixed biotech immunological products for bulk clinical use.